Skip to main content
. 2023 Aug 14;32:100700. doi: 10.1016/j.lanepe.2023.100700

Table 7.

Numbers of cases, sensitivity, specificity, and observed 10-year risk identified in each twentieth of predicted risk using the CanPredict algorithm in the QResearch validation cohort. Of 4,117,527 patients, 5014 developed oesophageal cancer during follow-up.

Top centile Threshold of predicted 10-year risk (%) Below threshold/no cancera Below threshold/cancerb Above threshold/no cancerc Above threshold/cancerd Sensitivity% Specificity% Observed 10-year risk %
Top 5% 0.97 3,908,150 3501 204,363 1513 30.18 95.03 1.44 (1.35, 1.53)
Top 10% 0.63 3,703,315 2460 409,198 2554 50.94 90.05 1.09 (1.04, 1.14)
Top 15% 0.44 3,498,143 1755 614,370 3259 65.00 85.06 0.89 (0.85, 0.93)
Top 20% 0.31 3,292,817 1205 819,696 3809 75.97 80.07 0.76 (0.73, 0.78)
Top 25% 0.22 3,087,333 813 1,025,180 4201 83.79 75.07 0.65 (0.63, 0.67)
Top 30% 0.16 2,881,714 555 1,230,799 4459 88.93 70.07 0.57 (0.55, 0.59)
Top 35% 0.11 2,676,016 377 1,436,497 4637 92.48 65.07 0.50 (0.48, 0.52)
Top 40% 0.08 2,470,282 235 1,642,231 4779 95.31 60.07 0.45 (0.43, 0.46)
Top 45% 0.05 2,264,481 159 1,848,032 4855 96.83 55.06 0.40 (0.39, 0.42)
Top 50% 0.04 2,058,662 102 2,053,851 4912 97.97 50.06 0.37 (0.36, 0.38)
Top 55% 0.02 1,852,824 64 2,259,689 4950 98.72 45.05 0.34 (0.33, 0.35)
Top 60% 0.017 1,646,966 45 2,465,547 4969 99.10 40.05 0.31 (0.30, 0.32)
Top 65% 0.012 1,441,103 32 2,671,410 4982 99.36 35.04 0.29 (0.28, 0.30)
Top 70% 0.008 1,235,237 22 2,877,276 4992 99.56 30.04 0.28 (0.27, 0.29)
Top 75% 0.006 1,029,367 15 3,083,146 4999 99.70 25.03 0.26 (0.25, 0.27)
Top 80% 0.004 823,497 9 3,289,016 5005 99.82 20.02 0.25 (0.24, 0.26)
Top 85% 0.003 617,624 6 3,494,889 5008 99.88 15.02 0.24 (0.23, 0.25)
Top 90% 0.002 411,748 5 3,700,765 5009 99.90 10.01 0.23 (0.22, 0.24)
Top 100% na 0 0 4,112,513 5014 100.0 0 0.22 (0.21, 0.23)
a

Observed number of individuals below the risk threshold who did not develop oesophageal cancer.

b

Observed number of individuals below the risk threshold who did develop oesophageal cancer.

c

Observed number of individuals above the risk threshold who did not develop oesophageal cancer.

d

Observed number of individuals above the risk threshold who did develop oesophageal cancer.